A method for the detection of virginiamycin M1 as a marker compound of virginiamycin at sub-additive level in pig, calf, piglet, sow, poultry, cattle and laying hen feeds was developed and validated. Both UV detection at 230 nm and MS detection were applied. Virginiamycin M1 was extracted from animal feeds with ethyl acetate after wetting of the feed with water followed by clean-up on Sep-Pak silica gel and OASIS HLB cartridges. Analysis of extracts was carried out on an Inertsil ODS-2 column with acetonitrile-water-formic acid as the mobile phase and UV detection at 230 nm. The limit of quantification (LOQ) of the method was 2.7 mg kg(-1). The proposed method was validated at a target species dependent minimum required performance limit (MRPL), at 2MRPL and at 5MRPL levels in pig, calf, piglet, sow, poultry, cattle and laying hen feeds. Recoveries at target species dependent MRPL levels ranged from 38 to 67%, within-day repeatabilities from 7 to 19% and within-laboratory reproducibilities from 13 to 27%. The proposed UV method is primarily suitable for screening purposes at subadditive levels, but semi-quantitative data can also be produced. Three MS detection modes (ion-source CID, full MS and MS2) were tested as an alternative and/or extension to UV detection. The selectivity and sensitivity of both LC-MS2 and LC-MS were much better than those of UV detection at 230 nm.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1039/b102931m | DOI Listing |
J Clin Neurosci
January 2025
Department of Radiology, Xuanwu Hospital, Capital Medical University, Beijing, PR China.
Background: High variability of intracranial arterial blood flow velocities by Transcranial color-coded sonography (TCCS) has been found in clinical practice. This study aimed to improve diagnostic accuracy by analyzing influencing factors of middle cerebral artery (MCA) blood flow velocity detected by TCCS.
Methods: In total, 328 MCA vessels were classified as normal (27.
Alzheimers Dement
December 2024
Department of Neurology and Neurological Sciences Stanford University School of Medicine, Stanford, CA, USA.
Background: Lewy body disease (LBD) often co-occurs with Alzheimer's disease neuropathological change (ADNC), which can be detected using plasma pTau181 and pTau217. Few studies have investigated these biomarkers in LBD, nor have studies investigated plasma pTau217 in Parkinson's disease (PD) cognitively normal patients (LBD-CN), or in alpha-synuclein positive (asyn-positive) participants. Furthermore, uncertainties remain regarding LBD-specific cut-points for these biomarkers.
View Article and Find Full Text PDFBackground: Sleep is impaired in dementia. Therefore, sleep has been proposed as an intervention target for incident dementia. The microstructures of sleep electroencephalography (EEG), such as spindle, slow oscillation (SO), and their coupling, have neuronal bases and functions in learning and memory.
View Article and Find Full Text PDFBackground: Tangle burden, one of the hallmarks of Alzheimer's Disease, is thought to accumulate and spread throughout the brain in a distinctive pattern starting from the entorhinal cortex following Braak stages as characterized in neuropathological studies. Longitudinal tau PET allows us to investigate in vivo the tau spread in an individual and substantial heterogeneity has been observed in the pattern of tau spread. In this analysis, we examine the statistical power of tau PET measurements in tracking disease progression using data from the ADNI cohort.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
University of Arizona College of Medicine Phoenix, Phoenix, AZ, USA.
Background: Tangle burden, one of the hallmarks of Alzheimer's Disease, is thought to accumulate and spread throughout the brain in a distinctive pattern starting from the entorhinal cortex following Braak stages as characterized in neuropathological studies. Longitudinal tau PET allows us to investigate in vivo the tau spread in an individual and substantial heterogeneity has been observed in the pattern of tau spread. In this analysis, we examine the statistical power of tau PET measurements in tracking disease progression using data from the ADNI cohort.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!